Targeting Wnt/β-catenin signaling enhances the efficacy of anti-CD38 immunotherapy in multiple myeloma

Background: Previous studies have shown that the Wnt/β-catenin signaling pathway is aberrantly activated in multiple myeloma (MM) and regulates the growth of MM cells, while recent studies reported crosstalk between Wnt and STAT3 signaling in various non-MM systems. In addition, it has been shown th...

Descripció completa

Dades bibliogràfiques

Autors principals:	Heng Li, Yunguang Chen, Michaela Gregorova, Tingting Yang, Xiayi Zhang, Xiaoyu Yu, Zhen Wang, Haiying Hua, Long Ye, Xiaowei Qi, Marcel Spaargaren, Steven T. Pals, Zemin Ren
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-12-01
Col·lecció:	Neoplasia: An International Journal for Oncology Research
Matèries:	Multiple myeloma Wnt/β-catenin STAT3 pathway CD38 Daratumumab
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1476558625001228
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!